| Tretinoin | Approved Investigational Nutraceutical | SYTL1 | 84958 |
upregulated | Tretinoin results in increased expression of SYTL1 mRNA | 1p36.11 | |
| Tretinoin | Approved Investigational Nutraceutical | SYTL2 | 54843 |
upregulated | Tretinoin results in increased expression of SYTL2 mRNA | 11q14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SYTL3 | 94120 |
upregulated | Tretinoin results in increased expression of SYTL3 mRNA | 6q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SYTL5 | 94122 |
upregulated | Tretinoin results in increased expression of SYTL5 mRNA | Xp11.4 | |
| Tretinoin | Approved Investigational Nutraceutical | SZRD1 | 26099 |
downregulated | Tretinoin results in decreased expression of SZRD1 mRNA | 1p36.13 | |
| Tretinoin | Approved Investigational Nutraceutical | TACSTD2 | 4070 |
upregulated | Tretinoin metabolite results in increased expression of TACSTD2 mRNA | 1p32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | TACSTD2 | 4070 |
upregulated | Tretinoin results in increased expression of TACSTD2 mRNA | 1p32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | TAF10 | 6881 |
upregulated | Tretinoin results in increased expression of TAF10 mRNA | 11p15.4 | |
| Tretinoin | Approved Investigational Nutraceutical | TAF1A | 9015 |
downregulated | Tretinoin results in decreased expression of TAF1A mRNA | 1q41 | |
| Tretinoin | Approved Investigational Nutraceutical | TAF4B | 6875 |
downregulated | Tretinoin results in decreased expression of TAF4B mRNA | 18q11.1 | |
| Tretinoin | Approved Investigational Nutraceutical | TAF9B | 51616 |
downregulated | Tretinoin results in decreased expression of TAF9B mRNA | Xq21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | TAGLN | 6876 |
upregulated | Tretinoin results in increased expression of TAGLN mRNA | 11q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | TANC1 | 85461 |
upregulated | Tretinoin results in increased expression of TANC1 mRNA | 2q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | TAP1 | 6890 |
upregulated | Tretinoin results in increased expression of TAP1 mRNA | 6p21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | TATDN1 | 83940 |
downregulated | Tretinoin results in decreased expression of TATDN1 mRNA | 8q24.13 | |
| Tretinoin | Approved Investigational Nutraceutical | TBATA | 219793 |
downregulated | Tretinoin results in decreased expression of TBATA mRNA | 10q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | TBC1D1 | 23216 |
upregulated | Tretinoin results in increased expression of TBC1D1 mRNA | 4p14 | |
| Tretinoin | Approved Investigational Nutraceutical | TBC1D3F | 84218 |
upregulated | Tretinoin results in increased expression of TBC1D3F mRNA | 17q12 | |
| Tretinoin | Approved Investigational Nutraceutical | TBC1D4 | 9882 |
downregulated | Tretinoin results in decreased expression of TBC1D4 mRNA | 13q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | TBC1D5 | 9779 |
downregulated | Tretinoin results in decreased expression of TBC1D5 mRNA | 3p24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | TBC1D8B | 54885 |
upregulated | Tretinoin results in increased expression of TBC1D8B mRNA | Xq22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | TBC1D9 | 23158 |
upregulated | Tretinoin results in increased expression of TBC1D9 mRNA | 4q31.21 | |
| Tretinoin | Approved Investigational Nutraceutical | TBKBP1 | 9755 |
downregulated | Tretinoin results in decreased expression of TBKBP1 mRNA | 17q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | TBL1X | 6907 |
downregulated | Tretinoin results in decreased expression of TBL1X mRNA | Xp22.31-p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | TBR1 | 10716 |
downregulated | Tretinoin results in decreased expression of TBR1 mRNA | 2q24.2 | |